SCHEMBL3225027

SCHEMBL3225027

C1CCN2CCC[C@H]2C1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL339598 1.00
SCHEMBL3232584 1.00
SCHEMBL38654566 1.00
SCHEMBL10384525 0.97 HTR6 (0.52)
SCHEMBL6194042 0.97 HTR6 (0.52)
SCHEMBL583879 0.97 HTR6 (0.56)
SCHEMBL127850 0.97 HTR6 (0.56)
SCHEMBL24782761 0.93 HTR6 (0.54)
SCHEMBL22216666 0.93 HTR6 (0.54)
SCHEMBL21057351 0.93 HTR6 (0.54)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3225614-B1 KINETIC RESOLUTION OF ASYMMETRIC CATALYTIC HYDROGENATION OF RACEMIC -HYDROXY ESTER AND APPLICATION THEREOF ZHEJIANG JIUZHOU PHARM CO LTD (CN) 2020-10-28 EP disclosed
US-20170334831-A1 Kinetic resolution of racemic hydroxy ester via asymmetric catalytic hydrogenation and application thereof ZHEJIANG JIUZHOU PHARMACEUTICAL CO., LTD. (CN) 2017-11-23 US disclosed
EP-3225614-A1 KINETIC RESOLUTION OF ASYMMETRIC CATALYTIC HYDROGENATION OF RACEMIC -HYDROXY ESTER AND APPLICATION THEREOF Zhejiang Jiuzhou Pharmaceutical Co., Ltd. (CN) 2017-10-04 EP disclosed
WO-2010049678-A2 TREATMENT OF ENERGY UTILIZATION DISEASES SUMMIT CORPORATION PLC (GB) 2010-05-06 WO disclosed
WO-2010029313-A1 ANTIINFECTIVE COMPOUNDS SUMMIT CORPORATION PLC. (GB) 2010-03-18 WO disclosed
WO-2010015815-A2 COMPOUNDS FOR THE TREATMENT OF FLAVIVIRAL INFECTIONS SUMMIT CORPORATION PLC (GB) 2010-02-11 WO disclosed